Oncogenic MNK signalling regulates the metastasis suppressor NDRG1

Shuye Tian1,2, Xuemin Wang1,2, Christopher G Proud1,2

  • 1Nutrition and Metabolism, South Australian Health and Medical Research Institute, Adelaide SA5000, Australia.

Oncotarget
|May 26, 2017
PubMed

Insights

The oncogenic MAP kinase-interacting kinase (MNK) pathway regulates N-myc down-regulated gene 1 (NDRG1) expression and phosphorylation, impacting breast cancer cell migration and metastasis. This reveals novel signaling connections crucial for tumor biology.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • N-myc down-regulated gene 1 (NDRG1) protein suppresses tumor metastasis.
  • NDRG1 is phosphorylated by serum and glucocorticoid-regulated kinase 1 (SGK1).
  • The MAP kinase-interacting kinase (MNK) pathway is a potential cancer therapy target.

Purpose of the Study:

  • To investigate the regulation of NDRG1 by the MNK pathway.
  • To elucidate the roles of MNK and SGK1 in cell migration and metastasis.
  • To uncover novel signaling connections in tumor biology.

Main Methods:

  • Investigated NDRG1 expression and phosphorylation in breast cancer cells following MNK inhibition.
  • Utilized knockout cell lines (MNK1, MNK2) to assess specific kinase roles.
  • Performed in vitro kinase assays to determine direct phosphorylation events.
  • Examined the effects of MNK and SGK1 inhibition on cell migration and invasion.

Main Results:

  • MNK inhibition increased NDRG1 protein and mRNA levels and decreased NDRG1 phosphorylation, specifically via MNK1.
  • MNK1 cannot directly phosphorylate NDRG1, suggesting indirect regulation.
  • SGK1 phosphorylates MNK1, repressing its activity.
  • MNK inhibition impaired cell migration regardless of NDRG1 levels, while SGK1 inhibition's effect was dependent on NDRG1 levels.

Conclusions:

  • The MNK signaling pathway regulates NDRG1 at both transcriptional and post-translational levels.
  • MNKs and SGK1 influence cell migration and invasion through distinct mechanisms.
  • Novel connections between MNK, SGK1, and NDRG1 signaling pathways in tumor biology were identified.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K